Gastroenterology and Hepatology

Medicine & Life Sciences

1. Barrett Esophagus 100%
2. Interstitial Cells of Cajal 96%
3. Gastroparesis 90%
4. Neoplasms 79%
5. Irritable Bowel Syndrome 73%
6. Endoscopy 72%
7. Liver Transplantation 67%
8. Stomach 66%
9. Cholangiocarcinoma 62%
10. Colonoscopy 57%
11. Gastric Emptying 55%
12. Polyps 53%
13. Pancreatic Neoplasms 51%
14. Therapeutics 42%
15. Hepatocellular Carcinoma 39%
16. Extracellular Vesicles 36%
17. Myotomy 35%
18. Endoscopic Ultrasound-Guided Fine Needle Aspiration 34%
19. Adenocarcinoma 33%
20. Lasers 32%
21. Endoscopic Mucosal Resection 31%
22. Multicenter Studies 30%
23. Adenoma 30%
24. Colon 29%
25. Confidence Intervals 28%
26. Liver Neoplasms 28%
27. Smooth Muscle 28%
28. Photochemotherapy 28%
29. Meta-Analysis 28%
30. Fine Needle Biopsy 27%
31. Constipation 27%
32. Safety 27%
33. Gastrointestinal Tract 27%
34. Colorectal Neoplasms 26%
35. Pancreatitis 26%
36. Biopsy 26%
37. Liver 26%
38. Inflammatory Bowel Diseases 24%
39. Genes 24%
40. Smooth Muscle Myocytes 23%
41. Gastrointestinal Diseases 23%
42. Weight Loss 23%
43. Pancreas 23%
44. Sclerosing Cholangitis 23%
45. Survival 23%
46. MicroRNAs 23%
47. Systematic Reviews 23%
48. Endosonography 22%
49. Stents 22%
50. Esophagus 22%
51. Chronic Pancreatitis 22%
52. Endoscopic Retrograde Cholangiopancreatography 21%
53. Crohn Disease 21%
54. Narrow Band Imaging 21%
55. Pathologic Constriction 20%
56. Meals 20%
57. Gastroenterology 20%
58. Fibrosis 20%
59. Mutation 20%
60. Technology 19%
61. Pancreatic Diseases 19%
62. Radiofrequency Ablation 18%
63. Recurrence 18%
64. Odds Ratio 18%
65. Obesity 18%
66. Gastroplasty 18%
67. Artificial Intelligence 17%
68. RNA 17%
69. Light 17%
70. Dyspepsia 17%
71. Swine 17%
72. Esophageal Achalasia 17%
73. Pancreatic Cyst 17%
74. Carbon Monoxide 16%
75. Long Noncoding RNA 16%
76. Esophageal Neoplasms 16%
77. Jejunum 16%
78. Gastric Bypass 16%
79. Endoscopes 16%
80. Biomarkers 16%
81. Mortality 16%
82. Lymph Nodes 16%
83. Bariatric Surgery 16%
84. Needles 15%
85. Gastrointestinal Motility 15%
86. Transplants 15%
87. Liver Diseases 15%
88. Placebos 15%
89. Serotonin 15%
90. Dihematoporphyrin Ether 14%
91. Equipment and Supplies 14%
92. Gastroenterologists 13%
93. Nausea 13%
94. Databases 13%
95. Prospective Studies 13%
96. Metaplasia 13%
97. Diarrhea 13%
98. Population 13%
99. Growth 13%